Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma
Johnson, D.M.; Hayat, S.Q.; Burton, G.V.
Journal of Rheumatology 26(4): 1009-1010
1999
ISSN/ISBN: 0315-162X PMID: 10229440 Document Number: 506836
Document emailed within 1 workday
Related Documents
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87Beiteke, U.; Ruppert, P.; Garbe, C.; Oxenfarth, R.; Kastl, I.; Türker, T.; Tronnier, H.; Frosch, P.J. 1993: Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 44(6): 365-371
Agarwala, S.S.; Kirkwood, J.M. 2002: Update on adjuvant interferon therapy for high-risk melanoma Oncology 16(9): 1177-87; Discussion 1190-2 1197
de Braud, F.; Biganzoli, L.; Bajetta, E.; Colleoni, M.; Zampino, M.G. 1993: Subcutaneous low-dose interleukin-2 plus alpha interferon in advanced malignant melanoma Tumori 79(3): 187-190
Schreml, W. 1982: Malignant melanoma - adjuvant systemic therapy Aktuelle Probleme in Chirurgie und Orthopadie 22: 64-65
Maral, J.; Steinberg, M.; Weil, M.; Chleq, C.; Khayat, D.; Banzet, P.; Jacquillat, C. 1987: Human recombinant leukocyte interferon alpha-2-A in 22 cases of metastatic malignant melanoma Presse Medicale 16(21): 1031-1034
Popov, I.; Jelić, S.; Kovcin, V. 1995: A pilot study of low dose alpha-2b interferon in metastatic malignant melanoma with predominant subcutaneous metastases Srpski Arhiv Za Celokupno Lekarstvo 123(1-2): 5-7
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Stadler, R.; Bratzke, B.; Orfanos, C.E. 1987: Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 38(8): 453-460
Basting, R.; Corvin, S.; Händel, D.; Hinke, A.; Schmidt, D. 1999: Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry Anticancer Research 19(2c): 1493-1495
Gandzha, I.M.; Sakharchuk, V.M.; Lysenko, G.I.; Mironova, K.A.; Galetskaia, T.M. 1981: Use of levamisole in the adjuvant therapy of rheumatoid arthritis and systemic lupus erythematosus Vrachebnoe Delo 2: 16-18
Liu, Y.-s.; Zhang, W.-d.; Yang, C.-h.; Sun, Y.-f.; Geng, B. 2006: Effect of interferon alfa therapy on malignant melanoma of oral mucosa Shanghai Kou Qiang Yi Xue 15(3): 263-268
Schuler, M.; Aulitzky, W.E.; Schneller, F.; Peschel, C.; Huber, C. 1995: Interferon-alpha in therapy of malignant hemoblastoses Der Internist 36(12): 1133-1138
Maini, R.N.; Brennan, F.M.; Williams, R.; Chu, C.Q.; Cope, A.P.; Gibbons, D.; Elliott, M.; Feldmann, M. 1993: TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy Clinical and Experimental Rheumatology 11(Suppl 8): S173-S175
Famularo, G. 2003: Blood TNF-alpha and combination therapy for rheumatoid arthritis Clinical and Experimental Rheumatology 21(3): 404
Carrozzini, B.; Selvaggio, G. 1982: Long-term therapy of rheumatoid arthritis with alpha-mercaptopropionylglycine Minerva Medica 73(19): 1301-1304
Feldmann, M.; Brennan, F.; Paleolog, E.; Taylor, P.; Maini, R.N. 1997: Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action European Cytokine Network 8(3): 297-300
Tajima, Y.; Yabe, N.; Morishige, S.; Tamura, E.; Sakimoto, Y.; Takenoya, T.; Oto, I.; Yoshikawa, T.; Osumi, K.; Murai, S. 2019: A Case of Small Bowel Perforation Caused by Malignant Lymphoma after Methotrexate Therapy for Rheumatoid Arthritis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(4): 736-738
Dhib, M.; Bakhache, E.; Postec, E.; Vanrenterghem, B.; Le Roy, F.; Azar, R.; François, A.; Boldron, A.; Amaria, R.; Ozenne, G.; Hermelin, A. 1996: Nephrotic syndrome complicating treatment with interferon alpha Presse Medicale 25(23): 1066-1068
Trandafir, L.; Ruffié, P.; Borel, C.; Monnet, I.; Soulié, P.; Adams, D.; Cvitkovic, E.; Armand, J.P. 1997: Higher doses of alpha-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma European Journal of Cancer 33(11): 1900-1902